Viatris (VTRS) Income Statement Flow — TTM through Q1 2026
Calculated from the four most recent reported quarters, ending (reported ).
Viatris (VTRS) Revenue by Product Segment — TTM through Q1 2026
Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported segments changed mid-year.
| Segment | Revenue (USD) | % of total |
|---|---|---|
| Brands | $9.43B | 64.7% |
| Generics | $5.13B | 35.3% |
| Total | $14.56B | 100% |
- Brands$9.43B
- Generics$5.13B
- Total$14.56B
Viatris (VTRS) Revenue by Geography — TTM through Q1 2026
Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported regions changed mid-year.
| Region | Revenue (USD) | % of total |
|---|---|---|
| Developed Markets Segment | $8.68B | 59.6% |
| Greater China Segment | $2.46B | 16.9% |
| Emerging Markets Segment | $2.23B | 15.3% |
| Japan, Australia and New Zealand Segment | $1.19B | 8.2% |
| Total | $14.56B | 100% |
- Developed Markets Segment
- Greater China Segment
- Emerging Markets Segment
- Japan, Australia and New Zealand Segment
- Total
Revenue Breakdown — TTM through Q1 2026
In TTM through Q1 2026, Viatris (VTRS) reports revenue across 2 operating segments; the largest segment was Brands at 64.7%, followed by Generics (35.3%). Separately, by end-market geography, Developed Markets Segment accounted for 59.6% of revenue, followed by Greater China Segment (16.9%) and Emerging Markets Segment (15.3%).
Frequently asked questions
Data & methodology
Viatris (VTRS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation